CISPLATIN DOSE INTENSITY IN NON-SMALL CELL LUNG-CANCER - PHASE-II RESULTS OF A DAY-1 AND DAY-8 HIGH-DOSE REGIMEN

被引：83
作者：
GANDARA, DR
WOLD, H
PEREZ, EA
DEISSEROTH, AB
DOROSHOW, J
MEYERS, F
MCWHIRTER, K
HANNIGAN, J
DEGREGORIO, MW
机构：
[1] UNIV CALIF DAVIS,DIV HEMATOL ONCOL,DAVIS,CA 95616
[2] UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143
[3] LETTERMAN ARMY MED CTR,HEMATOL ONCOL SERV,SAN FRANCISCO,CA 94129
[4] UNIV CALIF SAN FRANCISCO,DIV HEMATOL ONCOL,SAN FRANCISCO,CA 94143
[5] VET ADM MED CTR,SAN FRANCISCO,CA 94121
[6] CITY HOPE NATL MED CTR,DUARTE,CA 91010
[7] NO CALIF ONCOL GRP,BELMONT,CA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 10期
关键词：
D O I：
10.1093/jnci/81.10.790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：790 / 794
页数：5
相关论文
共 32 条
[1]   A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY WITH IMPROVED SELECTIVITY FOR CISPLATIN AND ACTIVE PLATINUM(II) COMPLEXES IN PLASMA ULTRAFILTRATE [J].
ANDREWS, PA ;
WUNG, WE ;
HOWELL, SB .
ANALYTICAL BIOCHEMISTRY, 1984, 143 (01) :46-56
[2]  
ARMITAGE P, 1971, STATISTICAL METHODS, P131
[3]  
BHUCHAR VK, 1982, CANCER TREAT REP, V66, P375
[4]  
BRITELL JC, 1978, CANCER TREAT REP, V62, P1207
[5]   HIGH-DOSE PLATINUM FOR THE TREATMENT OF REFRACTORY OVARIAN-CANCER [J].
BRUCKNER, HW ;
WALLACH, R ;
COHEN, CJ ;
DEPPE, G ;
KABAKOW, B ;
RATNER, L ;
HOLLAND, JF .
GYNECOLOGIC ONCOLOGY, 1981, 12 (01) :64-67
[6]   CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN [J].
CORDEN, BJ ;
FINE, RL ;
OZOLS, RF ;
COLLINS, JM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) :38-41
[7]  
DECREGORIO MW, 1986, P ASCO, V5, P38
[8]  
DEGREGORIO MW, 1985, CANCER CHEMOTH PHARM, V15, P183
[9]  
DEJAGER R, 1980, CANCER TREAT REP, V64, P1341
[10]  
FORASTIERE AA, 1987, CANCER CHEMOTH PHARM, V19, P155
1234